Clever Leaves Holdings Inc.
General ticker "CLVR" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $24.2K (TTM average)
Clever Leaves Holdings Inc. follows the US Stock Market performance with the rate: 0.4%.
Estimated limits based on current volatility of -130.6%: low 0.01$, high 0.03$
Factors to consider:
- Total employees count: 296 (-26.0%) as of 2023
- US accounted for 62.3% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Substantial doubt about continuing as a going concern, High costs and need for substantial funds, Limited operating history in evolving industry, Agricultural risks, Labor/talent shortage/retention
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.57$, 2.04$]
- 2024-12-30 to 2025-12-30 estimated range: [0.49$, 1.63$]
Financial Metrics affecting the CLVR estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -338.65 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 77.51 > 63.39
- Positive: Investing cash flow per share per price, % of 138.13 > -0.66
- Positive: Inventory ratio change, % of -10.47 <= -0.75
- Positive: Interest expense per share per price, % of 1.35 <= 3.41
- Negative: negative Net income
Short-term CLVR quotes
Long-term CLVR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $15.37MM | $16.41MM | $17.42MM |
| Operating Expenses | $54.07MM | $63.33MM | $33.01MM |
| Operating Income | $-38.70MM | $-46.92MM | $-15.59MM |
| Non-Operating Income | $-5.98MM | $2.83MM | $-4.13MM |
| Interest Expense | $6.82MM | $2.67MM | $0.05MM |
| R&D Expense | $1.55MM | $1.72MM | $1.14MM |
| Income(Loss) | $-44.68MM | $-44.09MM | $-19.73MM |
| Taxes | $0.95MM | $-6.29MM | $0.07MM |
| Other Income(Loss) | $0.00MM | $-28.43MM | $1.90MM |
| Profit(Loss)* | $-45.54MM | $-66.10MM | $-17.90MM |
| Stockholders Equity | $72.77MM | $40.41MM | $24.22MM |
| Inventory | $15.41MM | $8.40MM | $4.48MM |
| Assets | $116.16MM | $52.10MM | $31.24MM |
| Operating Cash Flow | $-36.23MM | $-29.07MM | $-11.51MM |
| Capital expenditure | $7.28MM | $1.31MM | $0.03MM |
| Investing Cash Flow | $-7.28MM | $1.19MM | $4.69MM |
| Financing Cash Flow | $1.83MM | $3.29MM | $0.66MM |
| Earnings Per Share** | $-53.18 | $-51.65 | $-11.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.